Certified by Founder Lodge
SURGE Therapeutics
United States - Cambridge, MA
START UP
1 Disclosed Funding Rounds $32,000,000
0 Participating Investments
-
Founded date
2018
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
SURGE seeks to dramatically improve cancer patient survival by disrupting how, when, and where cancer immunotherapy is deployed -- focusing 100% of the effective dose at the right place and a
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| July, 20 ,2023 | Series B | $32,000,000 |
Intuitive Ventures
8VC
KdT Ventures
Pitango
Camford Capital
Piedmont Capital
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
TRIANA Biomedicines | $120,000,000 | (Dec 4, 2025)
Ridley | $6,400,000 | (Dec 4, 2025)
Autolane | $7,400,000 | (Dec 4, 2025)
Juniper Biosciences | $40,000,000 | (Dec 4, 2025)
PineAI | $25,000,000 | (Dec 4, 2025)
